Spots Global Cancer Trial Database for Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Robotic Versus Thoracolaparoscopic Esophagectomy for Esophageal Cancer
Official Title: Robotic Versus Thoracolaparoscopic Esophagectomy for Carcinoma Esophagus: a Prospective Comparative Study
Study ID: NCT03727126
Conditions
Study Description
Brief Summary: Esophageal cancer is a debilitating condition. The treatment involved is complex requiring a combination of chemotherapy and surgery in most cases. Complete removal of the tumor and the adjacent lymph nodes is of utmost importance in improving the survival. Lymph node yield following surgery helps in proper staging of the disease and is an important prognosticating variable. It is hypothesized that the lymph node yield following robotic esophagectomy is higher than that following thoracolaparoscopic esophagectomy. The study aims to compare the short term oncological outcomes following robotic esophagectomy and thoracolaparoscopic esophagectomy for carcinoma esophagus.
Detailed Description:
Eligibility
Minimum Age:
Eligible Ages: CHILD, ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
GEM Hospital & Research Center, Chennai, Tamil Nadu, India
GEM Hospital & Research Center, Coimbatore, Tamil Nadu, India
Contact Details
Name: Chinnusamy Palanivelu, MS, MCh
Affiliation: GEM Hospital & Research Center
Role: PRINCIPAL_INVESTIGATOR
Name: Shankar Balasubramanian, MS, MRCS
Affiliation: GEM Hospital & Research Center
Role: STUDY_DIRECTOR
Name: Sandeep Sabnis, MS, DNB
Affiliation: GEM Hospital & Research Center
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
